Stock screenerAll disclosures →
EDGAR →
FHTX
Conviction 16HealthcareScan · Thu, Jun 25, 2026Three outside down
FHTX$4.02-1.47%
ResistanceSupportVol 14Vol MA14 162.46K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price4.02
Change-1.47%
Gap+1.35%
Rel volume1.57×
Avg volume158.68K
Avg $ vol632.14K
SMA 203.98
SMA 504.35
SMA 2004.83
Price vs 50-7.66%
Price vs 200-16.81%
MA stackbearish
50/200 cross—
Supertrenddown · 4.46
RSI (14)47
MACD hist0.04
MACD cross—
Stoch %K / %D55 / 64
ADX (14)16
+DI / −DI23 / 20
RSI divergence—
MACD divergence—
ATR %+5.52%
ADR %5.42%
52w high6.68
52w low3.53
From 52w high-39.82%
Above 52w low+13.88%
New 52w highNo
SqueezeOff
Bollinger width20.20%
%B0.55
Donchian pos56.00%
Donchian high4.40
Donchian low3.54
AVWAP (52w high)4.96
vs AVWAP high-19.01%
AVWAP (52w low)4.90
vs AVWAP low-17.88%
OBV trendFlat
Chaikin MF (20)-0.08
Today vs 20d1.57×
Avg vol (14d)162.46K
Avg vol (20d)158.68K
Avg $ vol (20d)632.14K
Market cap236.03M
RS 3m (vs SPY)-27.26%
RS 6m (vs SPY)-29.87%
RS line new highNo
Trend template1/8
Technical rank19.5
1 week-0.74%
1 month-8.01%
3 months-18.46%
6 months-30.45%
1 year-17.45%
YTD-22.54%
P/E-3.18
P/B-3.09
P/S7.64
P/FCF-2.74
EPS-1.18
Div yield—
ROE97.22%
ROA-33.44%
Debt/Eq0.00
Current2.92
EV/EBITDA-1.79
Gross margin—
Net margin-240.33%
Rev growth36.75%
EPS growth14.24%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value148.37M
Revenue3.27M
Net income-19.88M
Gross profit—
Free cash flow-86.15M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out58.71M
Employees106
ListedFri, Oct 23, 2020
Free float33.41M
Float %56.9%
Short interest1.47M
Days to cover8.2d
Short volume62.7%
Squeeze score58 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.23 · 4 est
Last EPS vs est−$0.29 vs −$0.28
Last surprise-3.6% miss
Setup gradeD
Conviction16 / 100
Pattern quality—
Tech rank19.5 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside down
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in FHTX
No recent disclosed trades by Congress in FHTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in FHTX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Biller Scott Director · Stock Options (Right to buy) · 2026-06-24 | Grant | 28K | $114K | 2026-06-24 | 2026-06-25 |
Cole Douglas G. Director · Stock Options (Right to buy) · 2026-06-24 | Grant | 28K | $114K | 2026-06-24 | 2026-06-25 |
Duty Stuart Director · Stock Options (Right to buy) · 2026-06-24 | Grant | 28K | $114K | 2026-06-24 | 2026-06-25 |
PARSHALL B LYNNE Director · Stock Options (Right to buy) · 2026-06-24 | Grant | 28K | $114K | 2026-06-24 | 2026-06-25 |
SMITH IAN F Director · Stock Options (Right to buy) · 2026-06-24 | Grant | 28K | $114K | 2026-06-24 | 2026-06-25 |
Lynch Thomas J. Jr. Director · Stock Options (Right to buy) · 2026-06-24 | Grant | 28K | $114K | 2026-06-24 | 2026-06-25 |
Mendelsohn Michael Director · Stock Options (Right to buy) · 2026-06-24 | Grant | 28K | $114K | 2026-06-24 | 2026-06-25 |
Gallagher Neil Director · Stock Options (Right to buy) · 2026-06-24 | Grant | 28K | $114K | 2026-06-24 | 2026-06-25 |
GILL SIMBA Director · Stock Options (Right to buy) · 2026-06-24 | Grant | 28K | $114K | 2026-06-24 | 2026-06-25 |
GOTTSCHALK ADRIAN Chief Executive Officer · Common Stock · 2026-04-10 | Gift | 59.21K | $0 | 2026-04-10 | 2026-04-13 |
SEC filings
EDGAR filings in FHTX · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.